Health care and the human genome: Regulatory challenge and response
The explosive growth in genetic knowledge and technologies at the turn of
the twenty-first century – propelled by the Human Genome Project (HGP)
and a wealth of related research programs – continues to test the coping
capacity of the American legal system. This chapter examines current law and its rationale and looks to the horizon for the shape of legal controversies
yet to come in two areas of regulatory law: (1) regulation of access to and
use of genetic information by health insurance companies, and (2) regulation
of gene transfer research, genetic engineering, and reproductive cloning.